ORE Part 1 human disease questions
Human disease in ORE Part 1 sits in Paper A. Questions test general pathology and the dental management of medically compromised patients: whether to treat, modify care or refer under UK guidance.
Updated 1 October 2026 · Checked against the sources listed below
Human disease · 8 questions
3 of 8
Question 1 · The medically compromised patient and oral aspects of human disease · Paper A
Which one of the following is required by the GDC's Standards for the Dental Team in relation to a patient's medical history?
Question 2 · General pathology and immunology · Paper A
A woman taking weekly methotrexate for rheumatoid arthritis has mouth ulcers, with no blisters, rash, genital ulcers or eye symptoms.
Which one of the following is the most likely cause?
Question 3 · General pathology and immunology · Paper A
A 19-year-old man has acute pericoronitis around a partially erupted lower right third molar. The gum over it is red, warm to the touch and swollen, it is painful to touch, and he cannot open his mouth fully.
Which one of the following sets names the five cardinal signs of acute inflammation that he shows?
Question 4 · General pathology and immunology · Paper A
A dental student has serum antibody to hepatitis B surface antigen measured after two doses of hepatitis B vaccine given six months apart. The results are shown.
Serum antibody to the vaccine antigen (arbitrary units) Day after dose After first dose After second dose 3 0 25 7 3 160 10 20 300 14 18 280 28 10 200 Which one of the following best explains the difference between the two responses?
Question 5 · General pathology and immunology · Paper A
A 56-year-old woman has painful oral erosions and fragile blisters. A perilesional biopsy examined by direct immunofluorescence shows IgG deposited around the epithelial cells, and a diagnosis of pemphigus vulgaris is made.
Which one of the following hypersensitivity mechanisms best explains her condition?
Question 6 · General pathology and immunology · Paper A
A 74-year-old woman has worn a complete upper denture for 20 years. The upper alveolar ridge is now low and flat. Beneath the labial flange of the denture there is a soft fold of normal-coloured mucosa, and a biopsy of the fold shows normal-looking cells in increased numbers.
Which one of the following terms best describes the reduction in height of the alveolar ridge itself?
Question 7 · Systemic disease and its impact on dental care · Paper A
A 58-year-old man attends a general dental practice in England nine months after completing radiotherapy to the right side of his neck and oropharynx for a squamous cell carcinoma of the tonsil. Over three months his mouth opening has reduced gradually from 38 mm to 24 mm. He has little pain. The oral mucosa is intact with no ulceration, no bone is exposed, the teeth are not tender to percussion and he has no fever. His oncology team found no sign of recurrence at review last month.
Which one of the following best explains the reduced mouth opening?
Question 8 · Systemic disease and its impact on dental care · Paper A
A 29-year-old woman who is breastfeeding her 10-week-old baby attends a general dental practice in England. She has a painful, unrestorable lower right second permanent molar that needs extraction under local anaesthesia. She has no allergies and takes no regular medicines, and she asks whether she must stop breastfeeding.
Which one of the following is the most appropriate local anaesthetic advice?
What ORE Part 1 tests in human disease
The provider's blueprint lists two human disease topics among the eleven in Paper A. They are Human Disease relevant to dentistry and Oral aspects of human disease. It gives no weighting for any topic. Questions range from general pathology and immunology to the systemic diseases that change dental care. Many describe a patient's medical history and ask whether to treat as normal, modify the treatment or refer. The specification maps the GDC's Preparing for Practice outcome on managing the impact of medical conditions to Part 1. The GDC's Standards require an up-to-date medical history each time a patient is treated.
Treat, modify or refer: the UK rules
| Patient | The decision a question tests | UK source |
|---|---|---|
| High risk of infective endocarditis: previous endocarditis, a prosthetic valve or valve repair material, untreated cyanotic congenital heart disease, a ventricular assist device | Antibiotic prophylaxis offered before extractions and oral surgery, and considered for procedures that manipulate the gingival or periapical tissues, as a shared decision | NICE CG64; SDCEP implementation advice |
| Moderate risk of infective endocarditis: rheumatic heart disease, a bicuspid aortic valve, an implanted cardiac electronic device such as a pacemaker | No prophylaxis unless the cardiac team has specified it | SDCEP implementation advice |
| Bisphosphonates, denosumab or anti-angiogenic drugs | Risk assessed and recorded as low or higher; straightforward extractions in primary care, with alternatives explored first at higher risk | SDCEP MRONJ guidance |
| Haemophilia and other inherited bleeding disorders | Liaison with the haemophilia centre; cover for an inferior dental block or lingual infiltration; most extractions in hospital | UKHCDO guidance |
| Diabetes | An increased risk of periodontal disease assumed for every patient with diabetes; periodontal treatment may improve diabetes control | Delivering Better Oral Health |
| Renal impairment, liver impairment and pregnancy | Ibuprofen avoided where possible in renal impairment and in severe hepatic impairment; in pregnancy avoided in the third trimester and in the first two unless essential | BNF |
SDCEP's MRONJ guidance classes a patient as low risk when osteoporosis or another non-malignant bone disease is treated with bisphosphonates for less than 5 years, or with denosumab, without systemic glucocorticoids. Cancer patients are higher risk. Patients taking anticoagulant or antiplatelet drugs are covered on the pharmacology page with SDCEP's rules, and collapse in the chair on the medical emergencies page.
Where candidates go wrong
These traps come from the guidance behind the questions.
- The MRONJ definition applied too early. MRONJ is exposed bone, or bone that can be probed through a fistula, in the maxillofacial region for more than eight weeks after antiresorptive or anti-angiogenic drugs, with no radiotherapy to the jaws and no obvious metastatic disease there. A socket exposed for six weeks does not meet it, and denosumab counts although it is not a bisphosphonate.
- A drug holiday advised by the dentist. SDCEP finds no evidence that stopping bisphosphonates before treatment lowers the risk, because the drugs persist in bone for years. The decision belongs to the prescriber.
- Antibiotics given to prevent MRONJ. SDCEP advises against antibiotic or antiseptic prophylaxis after extractions for this purpose. A socket that has not healed at eight weeks is referred.
- Chlorhexidine offered instead of prophylaxis. NICE CG64 says chlorhexidine mouthwash should not be offered as prophylaxis against infective endocarditis.
- An inferior dental block given by habit in haemophilia. Buccal infiltration can be used without cover for all upper teeth and for the buccal side of the lower incisors, canines and premolars.
- A medical history taken once. The GDC requires it to be kept up to date each time the patient is treated.
How to revise human disease
Learn the topic by condition: the risk groups, what changes in the dental plan and the point at which care moves to a specialist. Then practise on scenarios, because a question gives the medical history and leaves the risk category to you. Read SDCEP's MRONJ guidance and its endocarditis implementation advice, which set out the risk groups that these questions turn on. The Paper A questions set human disease among the sciences, and the free diagnostic gives a first read on every subject.
Questions candidates ask
Paper A. The provider's blueprint lists Human Disease relevant to dentistry and Oral aspects of human disease among the Paper A topics. Special care and therapeutics are separate topics in Paper B.
NICE does not recommend routine prophylaxis for dental procedures and refers to SDCEP for patients at high risk. SDCEP advises offering prophylaxis before extractions and oral surgery to high-risk patients, such as those with a previous endocarditis or a prosthetic valve, as a shared decision. Patients at moderate risk, such as those with rheumatic heart disease or a bicuspid aortic valve, do not need it unless their cardiac team has specified it.
Yes. SDCEP's MRONJ guidance keeps straightforward extractions in primary care for low-risk and higher-risk patients, after a recorded risk assessment and valid consent. For higher-risk patients the alternatives to extraction are explored first, and no antibiotic or antiseptic prophylaxis is given to reduce the risk of MRONJ.
Only with cover arranged through the haemophilia centre. UK guidance for dental practitioners says clotting factor is usually needed only for an inferior dental block or a lingual infiltration. Buccal and intrapapillary infiltrations need no cover.
Sources
- UCL consortium for the GDC: ORE Examination Specification for Candidates (August 2026)Checked 9 October 2026
- GDC: Standards for the Dental Team, the nine principlesChecked 28 September 2026
- NICE: Prophylaxis against infective endocarditis (CG64, March 2008, last updated July 2016)Checked 1 October 2026
- SDCEP: Antibiotic Prophylaxis Against Infective Endocarditis, implementation adviceChecked 28 September 2026
- SDCEP: Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw (March 2017, reviewed and extant March 2024)Checked 1 October 2026
- UKHCDO Dental Working Party: Guidance on the dental management of patients with haemophilia and congenital bleeding disorders, Br Dent J 2013;215:497-504Checked 1 October 2026
- The Haemophilia Society: Guidance for dental practitioners, the dental management of adult patients with haemophilia and other congenital bleeding disordersChecked 1 October 2026
- DHSC and NHS England: Delivering Better Oral Health, an evidence-based toolkit for prevention (4th edition, September 2021, updated September 2025)Checked 1 October 2026
- BNF (NICE): Ibuprofen, pregnancy, renal impairment and hepatic impairmentChecked 1 October 2026
- SDCEP: Management of Dental Patients Taking Anticoagulants or Antiplatelet DrugsChecked 28 September 2026
ORE Practice is independent of the General Dental Council. Rules, dates and fees can change: the GDC is the authority, and this page is checked against it.
Check human disease against the rest of Part 1
Human disease takes two of the eleven Paper A topics in the provider's blueprint. The free diagnostic asks 20 questions across Paper A and Paper B in about 15 minutes and gives a first read on every subject.
20 questions · about 15 minutes · free, no card details